XY Capital’s Ascentage Pharma AAPG Stock Holding History

XY Capital’s Portfolio AAPG Stock Details AAPG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,014	Closed	-$311K	–	141
2026 Q1	$311K	Sell	13,014 -614	-5%	-$15.1K	0.31%	39
2025 Q4	$358K	Sell	13,628 -4,492	-25%	-$147K	0.23%	94
2025 Q3	$707K	Buy	18,120 +12,530	+224%	+$507K	0.37%	68
2025 Q2	$220K	Sell	5,590 -17,915	-76%	-$472K	0.15%	37
2025 Q1	$516K	Buy	+23,505	New	+$446K	0.15%	117

Other funds holding AAPG

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

XY Capital's AAPG Position: Q2 2026 in Review

XY Capital sold out of Ascentage Pharma (AAPG) in Q2 2026, closing a stake of 13,014 shares — an estimated $311K sold.

XY Capital first reported a position in AAPG in Q1 2025 and held it in 5 quarters. The position peaked at $707K in Q3 2025. 8 funds tracked by Wall St. Rank hold AAPG as of Q2 2026.

XY Capital reported no remaining Ascentage Pharma position as of Q2 2026 after selling out during the quarter.
XY Capital sold 13,014 Ascentage Pharma shares in Q2 2026, an estimated $311K.
XY Capital first reported a position in Ascentage Pharma in Q1 2025 and held it in 5 quarters.
XY Capital's Ascentage Pharma position peaked at $707K in Q3 2025.
8 funds tracked by Wall St. Rank held Ascentage Pharma as of Q2 2026.

Based on XY Capital's 13F filing for Q2 2026, filed 11 Aug 2026.